Compass Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31M Buy
+6,093
New +$6.23M 1.38% 18
2025
Q4
Sell
-6,203
Closed -$4.73M 118
2025
Q3
$4.73M Buy
6,203
+75
+1% +$55.8K 1.06% 33
2025
Q2
$4.78M Hold
6,128
1.14% 33
2025
Q1
$5.06M Sell
6,128
-502
-8% -$418K 1.29% 24
2024
Q4
$5.12M Sell
6,630
-110
-2% -$91.1K 1.23% 24
2024
Q3
$5.97M Sell
6,740
-440
-6% -$396K 1.41% 21
2024
Q2
$6.5M Sell
7,180
-125
-2% -$100K 1.6% 11
2024
Q1
$5.68M Sell
7,305
-420
-5% -$299K 1.42% 17
2023
Q4
$4.5M Sell
7,725
-345
-4% -$201K 1.26% 24
2023
Q3
$4.33M Sell
8,070
-630
-7% -$325K 1.36% 19
2023
Q2
$4.08M Sell
8,700
-125
-1% -$52.4K 1.23% 28
2023
Q1
$3.03M Sell
8,825
-261
-3% -$88K 0.96% 38
2022
Q4
$3.32M Buy
+9,086
New +$3.22M 1.09% 33

Other funds holding LLY

Compass Wealth Management's LLY Position: Q2 2026 in Review

Compass Wealth Management opened a new position in Eli Lilly (LLY) in Q2 2026: 6,093 shares worth $7.31M. The stake represents 1.38% of the portfolio and ranks #18 among its holdings. This is a return to the name: Compass Wealth Management previously reported a position in LLY as recently as Q3 2025.

Compass Wealth Management first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Compass Wealth Management held 6,093 shares of Eli Lilly worth $7.31M as of Q2 2026.
  • Eli Lilly was a new Compass Wealth Management position in Q2 2026.
  • Eli Lilly made up 1.38% of Compass Wealth Management's portfolio in Q2 2026, its #18 holding.
  • Compass Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Compass Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.